RxSight director granted 37,037 RSUs

Andrews Julie reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Andrews Julie reported acquisition or exercise transactions in this Form 4 filing.

RxSight, Inc. director Julie Andrews received a grant of 37,037 restricted stock units, each representing a right to one share of common stock at no cost. The RSUs vest in full on the earlier of the one-year anniversary of the June 17, 2026 grant date or the next annual stockholder meeting, contingent on her continuing as an Outside Director. Following this award, she holds 78,076 shares directly.

Insider Trade Summary

Grant/Award: 37,037 shares

Grant/Award 1 txn

Insider Andrews Julie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	37,037	$0.00	$0.00

Holdings After Transaction: Common Stock — 78,076 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
2. F2. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Key Figures

RSUs granted: 37,037 RSUs Shares held after grant: 78,076 shares Grant price per share: $0.0000 per share +3 more

6 metrics

RSUs granted 37,037 RSUs Restricted stock unit award to director Julie Andrews on June 17, 2026

Shares held after grant 78,076 shares Total direct holdings following RSU award

Grant price per share $0.0000 per share Reported transaction price for the RSU grant

Vesting portion 100% of RSUs All RSUs vest on a single date if service conditions are met

Grant date June 17, 2026 Defined as the Date of Grant for vesting purposes

Vesting timing Earlier of 1 year or next meeting Vesting on one-year anniversary of grant or next annual stockholder meeting

Key Terms

restricted stock unit ("RSU"), Outside Director, 2021 Equity Incentive Plan, annual meeting of stockholders, +1 more

5 terms

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock."

Outside Director financial

"Subject to the Reporting Person's continuing as an Outside Director through such applicable vesting date..."

2021 Equity Incentive Plan financial

"Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date..."

annual meeting of stockholders financial

"the date of the next annual meeting of stockholders following the Date of Grant."

Date of Grant financial

""Date of Grant" shall mean June 17, 2026."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RxSight (RXST) director Julie Andrews report in this Form 4?

Julie Andrews reported receiving 37,037 restricted stock units in RxSight common stock at no cost. Each RSU represents one share, increasing her direct holdings to 78,076 shares after the award.

How many RxSight (RXST) shares does Julie Andrews hold after the RSU grant?

After the restricted stock unit grant, Julie Andrews directly holds 78,076 shares of RxSight common stock. This reflects the addition of 37,037 RSUs awarded as part of this reported transaction.

When do Julie Andrews’ RxSight (RXST) RSUs vest?

All of the RSUs vest on the earlier of the one-year anniversary of the June 17, 2026 grant date or the next annual stockholder meeting. Vesting requires that she continue serving as an Outside Director.

What does each restricted stock unit (RSU) in RxSight (RXST) represent?

Each restricted stock unit represents a contingent right to receive one share of RxSight common stock. The shares are delivered only if the vesting conditions, including continued service as an Outside Director, are satisfied.

Was there a purchase price for Julie Andrews’ RxSight (RXST) RSU grant?

The RSU grant was reported with a per-share price of $0.0000, indicating no cash paid for the award. It is a stock-based grant subject to service-based vesting conditions under the company’s equity plan.

What role does Julie Andrews hold at RxSight (RXST) related to this grant?

Julie Andrews is identified as a director of RxSight and an Outside Director under the 2021 Equity Incentive Plan. Her continued service in this role is required for the RSUs to fully vest as scheduled.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:06 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Andrews Julie

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/17/2026		A		37,037(2)	A	(1)	78,076	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.

2. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jim Schindler, as Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)